ARTICLE | Clinical News
Xarelto rivaroxaban regulatory update
April 27, 2009 7:00 AM UTC
The U.K.'s NICE issued final guidance recommending use of Xarelto rivaroxaban from Bayer to prevent venous thromboembolism (VTE) in adults having elective total hip or knee replacement surgery. The gu...